- Home
- ARDT vs CNTA Comparison
ARDT vs CNTA Comparison
Compare ARDT & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDT
- CNTA
- Stock Information
- Founded
- ARDT 2001
- CNTA 2020
- Country
- ARDT United States
- CNTA United Kingdom
- Employees
- ARDT N/A
- CNTA N/A
- Industry
- ARDT
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- ARDT
- CNTA Health Care
- Exchange
- ARDT NYSE
- CNTA Nasdaq
- Market Cap
- ARDT 2.8B
- CNTA 2.3B
- IPO Year
- ARDT 2024
- CNTA 2021
- Fundamental
- Price
- ARDT $16.76
- CNTA $17.46
- Analyst Decision
- ARDT Buy
- CNTA Strong Buy
- Analyst Count
- ARDT 11
- CNTA 7
- Target Price
- ARDT $22.09
- CNTA $23.71
- AVG Volume (30 Days)
- ARDT 232.4K
- CNTA 688.3K
- Earning Date
- ARDT 11-06-2024
- CNTA 11-12-2024
- Dividend Yield
- ARDT N/A
- CNTA N/A
- EPS Growth
- ARDT N/A
- CNTA N/A
- EPS
- ARDT 0.64
- CNTA N/A
- Revenue
- ARDT $5,705,817,000.00
- CNTA $6,853,000.00
- Revenue This Year
- ARDT $10.16
- CNTA N/A
- Revenue Next Year
- ARDT $7.84
- CNTA N/A
- P/E Ratio
- ARDT $25.96
- CNTA N/A
- Revenue Growth
- ARDT 11.23
- CNTA N/A
- 52 Week Low
- ARDT $14.58
- CNTA $6.65
- 52 Week High
- ARDT $20.72
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- ARDT N/A
- CNTA 51.71
- Support Level
- ARDT N/A
- CNTA $15.88
- Resistance Level
- ARDT N/A
- CNTA $18.12
- Average True Range (ATR)
- ARDT 0.00
- CNTA 0.95
- MACD
- ARDT 0.00
- CNTA -0.09
- Stochastic Oscillator
- ARDT 0.00
- CNTA 44.17
About ARDT ARDENT HEALTH PARTNERS INC
Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.